Function is a multidimensional concept that is emerging as an important aspect of clinical benefit assessment across therapy areas, as well as a concept that matters greatly for patients (and families), regulators, HTA groups, clinicians and payers when making medical decisions.
The aims of the symposium are to discuss definitions and concepts of functioning, to identify fit-for-purpose approaches to measurement (including novel technologies) and to identify evidence needs for different stakeholders, including regulators, payers, clinicians and patients. By organizing a range of stakeholders together, we hope to inspire collaboration across fields, and further strategies to generate meaningful data on patients’ functioning in clinical trials.
Co-Chairs: Tom Willgoss, Jennifer A. Petersen, Andrew E. Mulberg
ISOQOL Board Liaison: Diana Rofail